Vitalism Bay
0
%
SIGN UP

Apr 4 - May 29. 2025

8-Week Longevity Zone

Berkeley, CA

VB main saturated
The biggest
longevity event
in the world.
exercise outside
vb stage 1

About

Vitalist Bay is an 8-week longevity zone in Berkeley, California bringing the world’s best minds together to extend human healthspan & solve aging.

200+

Speakers

70

On campus residents  

Longevity's new capital

Join Our Investor Conference

Longevity Investor Forum!

Experience the most ambitious longevity event series in the world.

01

A 2-Day Immersive Longevity Event with 20+ top speakers & a dynamic community of leading investors.

Learn from the best—attend expert-led conversations, explore cutting edge treatments, enjoy an epic spa, and move your body with yoga, HIIT, and more.

woman doing workshop
longevity playground map
02

Explore the longevity playground

Get your biomarkers measured on site.
Experience top health & performance tools.

🩻 DEXA scan
♨️ Sauna
🩸Blood tests
🧬 Genomics 
❄️ Cold plunge 
🔬 Stem cells 
03

Connect in an intimate environment

Meet other like-minded people in a one-of-a-kind venue designed for real conversations. Expand your network.

2

May 3-4

Investors Week / May 2 - 8
A deep dive into the longevity investment landscape, featuring insights on capital allocation, past successes, and emerging opportunities. Designed for investors—both seasoned and new—this conference offers a roadmap for navigating the fast-growing longevity sector.
Longevity Science

Longevity Investors Summit Schedule

Buy a ticket

Regular

Longevity Investors Forum (May 3 - 4)

$525

check-circle
Access all conference sessions
check-circle
Network with industry leaders
check-circle
Yoga, Ecstatic Dance, Meditation & more
check-circle
Healthy Breakfast and Lunch
check-circle
Sauna, Cold Plunge

VIP

Longevity Investors Forum (May 3 - 4)

$1575

check-circle
Everything in Regular ticket
check-circle
Private Longevity Lounge
check-circle
Private Speaker + VIP dinner
check-circle
All week access to Vitalist Bay Spa
check-circle
Blood Banking
check-circle
DEXA Scan
check-circle
2 CGMs + Guidance (retail: $175)
check-circle
Phy Health Mobility Scan
check-circle
100+ Indicator Blood test with private medical consultation
Omri Amirav-Drory
General Partner, NFX
close-outline

Omri Amriav-Drory is a scientist and entrepreneur, currently serving as the General Partner at NFX Bio. He is the Founder and CEO of Renewal Bio, a company focused on developing innovative solutions in the field of biotechnology. Omri previously founded Genome Compiler, which was acquired by Twist Bioscience, and has played a pivotal role in scaling and investing in influential techbio companies. His unique blend of scientific expertise and entrepreneurial experience makes him a significant figure in the techbio industry.

Relevant Content
Omri Amirav-Drory
Omri Amirav-Drory
General Partner, NFX
Anastasiya Giarletta
Investor, R42 Group
close-outline

Anastasiya Giarletta is a prominent figure in the longevity and biotech sectors, serving as an advisor and co-founder of Aikora Health and an investor at R42 Group. Based in Silicon Valley and London, she focuses on connecting venture funds, angels, and entrepreneurs within the early-stage longevity ecosystem. Anastasiya is also a Teaching Assistant at Stanford University School of Medicine, where she lectures on Longevity Venture Capital and Healthcare Venture Capital. Her extensive network and expertise make her a key influencer in advancing healthcare and human aging technologies.

Relevant Content
Anastasiya Giarletta
Anastasiya Giarletta
Investor, R42 Group
Phil Newman
Founder & CEO, Longevity.Technology
close-outline

Phil Newman is the Founder and CEO of Longevity.Technology, a leading media and investment platform focused on the longevity megatrend. He has held multiple C-level management positions, applying his marketing and business development expertise in sectors such as longevity, IoT, bionics, medical devices, biopharma, and 3D manufacturing. Phil's work aims to bring together innovators and investors to commercialize companies that will form the longevity economy.

Relevant Content
Phil Newman
Phil Newman
Founder & CEO, Longevity.Technology
Daniel Ives
Founder & CEO, Shift Bioscience
close-outline

Daniel Ives is the CEO and founder of Shift Bioscience, a company dedicated to reversing cellular aging using AI-guided cellular rejuvenation techniques. With a background in mitochondrial biology from the University of Cambridge, Daniel has been at the forefront of developing innovative solutions to combat age-related diseases. His work focuses on leveraging advanced machine learning and epigenetic aging clocks to discover new therapeutic interventions that can extend human healthspan.

Relevant Content
Daniel Ives
Daniel Ives
Founder & CEO, Shift Bioscience
Emil Kendziorra
Founder & CEO, Tomorrow Bio
close-outline

Dr. Emil Kendziorra is the Founder and CEO of Tomorrow.Bio, a startup dedicated to advancing biostasis (cryonics) research and providing human cryopreservation services. He graduated summa cum laude from the University of Göttingen and has extensive experience in cancer research and entrepreneurship. Dr. Kendziorra has founded and led multiple tech and medical startups, including MedLanes and onFeedback. His vision is to build an organization that significantly contributes to the field of cryonics and promotes public awareness about its potential.

Relevant Content
Emil Kendziorra
Emil Kendziorra
Founder & CEO, Tomorrow Bio
Karl Pfleger
Founder, AgingBiotech.Info
close-outline

Karl Pfleger is a prominent angel investor and advocate for longevity research, known for his significant contributions to the biotech industry. He is an investor in Repair Biotechnologies, focusing on gene therapy for age-related diseases, and runs Aging Biotech Info, a valuable resource for the longevity community. Karl's background in machine learning and his dedication to supporting groundbreaking research make him a key figure in the fight against aging.

Relevant Content
Karl Pfleger
Karl Pfleger
Founder, AgingBiotech.Info
Ole Mensching
Co–founder, Apollo Health Ventures
close-outline

Ole Mensching, Ph.D., is the co-founder and General Partner of Apollo Ventures, a venture capital fund dedicated to aging and age-related diseases. He has a strong background in investment and operations, previously co-founding CareerTeam, a successful headhunting agency. Ole holds a Ph.D. from the University of California, Berkeley, and the University of Cologne, and his expertise in HR and team building has been instrumental in supporting Apollo's portfolio companies.

Relevant Content
Ole Mensching
Ole Mensching
Co–founder, Apollo Health Ventures
Sebastian Brunemeier
Partner, Healthspan Capital
close-outline

Sebastian Brunemeier is a biotech venture capitalist and company builder focused on longevity and regenerative medicine. He is the co-founder and General Partner of Healthspan Capital and the CEO and founder of ImmuneAGE Bio, a company dedicated to immune system rejuvenation. Sebastian has co-founded several longevity biotech companies, contributing to significant advancements in the field. His extensive experience and dedication to improving human healthspan have made him a respected figure in the biotech industry.

Relevant Content
Sebastian Brunemeier
Sebastian Brunemeier
Partner, Healthspan Capital
David Gobel
Founder & CEO, Methuselah Foundation
close-outline

David Gobel is a philanthropist, entrepreneur, inventor, and futurist, best known for co-founding the Methuselah Foundation, which focuses on extending healthy human lifespans through regenerative medicine and biotechnology. He has been a driving force in promoting the concept of longevity escape velocity and has supported numerous projects and companies aimed at combating age-related diseases. David's visionary work continues to inspire advancements in the field of life extension.

Relevant Content
David Gobel
David Gobel
Founder & CEO, Methuselah Foundation
Anar Isman
CEO, AgelessRx
close-outline

Anar Isman is the co-founder and CEO of AgelessRx, a telemedicine platform dedicated to slowing down the aging process through scientifically-backed interventions. With a background in investment management, Anar transitioned to the field of longevity science driven by a desire to make a meaningful impact on human health. He believes in making cutting-edge longevity treatments accessible to everyone and is passionate about advancing the field to help people live healthier, longer lives.

Relevant Content
Anar Isman
Anar Isman
CEO, AgelessRx
Aykut Karaalioglu
Founder & CEO, MobileAction
close-outline

Aykut Karaalioglu is an accomplished entrepreneur and investor, best known for founding MobileAction, a company specializing in app discovery and optimization. He has held various leadership roles, including CEO of SearchAds.comand Growth Lead at ScoreBeyond. Aykut is also an active angel investor and advisor to several startups, leveraging his extensive experience in product management and user acquisition to drive innovation and growth in the tech industry.

Relevant Content
Aykut Karaalioglu
Aykut Karaalioglu
Founder & CEO, MobileAction
Matthew O'Connor
Co–CEO, Cyclarity Therapeutics
close-outline

Matthew "Oki" O'Connor is the Co-CEO of Cyclarity Therapeutics, a company focused on developing treatments for cardiovascular diseases through innovative cyclodextrin technology. With a Ph.D. in Biochemistry and extensive research experience in aging and regenerative medicine, O'Connor has made significant contributions to the field. His work aims to eliminate toxic oxidized cholesterol, a major factor in atherosclerosis, and improve overall healthspan.

Relevant Content
Matthew O'Connor
Matthew O'Connor
Co–CEO, Cyclarity Therapeutics
Mac Davis
Co–founder, Minicircle
close-outline

Mac Davis is the founder of Minicircle, a pioneering company focused on revolutionizing gene therapy. With a mission to enhance human health and sovereignty, he developed a reversible human genetic enhancement protocol that uses non-inflammatory, non-heritable plasmids to safely introduce genes into the body without altering the genome. Mac’s innovative approach challenges traditional medical practices, offering a fast, accessible, and ethical alternative to lifelong treatments. His work aims to empower individuals and communities, ensuring that gene therapy is available to all, free from the constraints of the current healthcare system.

Relevant Content
Mac Davis
Mac Davis
Co–founder, Minicircle
Parmita Mishra
Founder, Precigenetics
close-outline

Parmita Mishra is a computational biologist and entrepreneur, known for founding Precigenetics, a company focused on developing advanced non-invasive diagnostic tools that integrate biophotonics with machine learning. She is dedicated to pushing the boundaries of healthcare technology, particularly in the field of non-invasive cancer diagnostics. Parmita's work aims to enhance the identification of molecular signatures unique to cancerous cells, leveraging machine learning algorithms to improve detection and classification.

Relevant Content
Parmita Mishra
Parmita Mishra
Founder, Precigenetics
Kevin Caldwell
CEO, Co-Founder & President, Ossium Health
close-outline

Kevin Caldwell is the co-founder, President, and CEO of Ossium Health, a pioneering bioengineering company focused on creating the world's first bone marrow bank for transplants. With a background in physics and economics from MIT and a JD from Harvard Law School, Kevin has also worked as an Engagement Manager at McKinsey and a Senior Investment Associate at Bridgewater Associates. His diverse experience and dedication to improving human health through innovative solutions make him a significant figure in the biotech industry.

Relevant Content
Kevin Caldwell
Kevin Caldwell
CEO, Co-Founder & President, Ossium Health
Nish Bhat
Co-Founder, Carbon Silicon VC
close-outline

Nish Bhat is an entrepreneur and investor with extensive experience in biotechnology and venture capital. He is the Founder and General Partner of Carbon Silicon Ventures, a firm dedicated to supporting startups that integrate engineering principles with biological sciences to drive innovation in healthcare. Before establishing Carbon Silicon Ventures, Mr. Bhat co-founded Color Health, Inc. in 2013, a company specializing in genetic testing services for various hereditary cancers. He also co-founded SciFounders, a venture capital firm launched in 2021, and serves on the board of Reference Medicine, a company focused on making specimens more affordable and accessible for oncology diagnostic developers. His journey reflects a commitment to advancing the intersection of biology and engineering, aiming to transform healthcare through innovative solutions.

Relevant Content
Nish Bhat
Nish Bhat
Co-Founder, Carbon Silicon VC
Dave Messina
General Partner, Pioneer Fund
close-outline

Dr. Dave Messina is an entrepreneur and scientist with over 25 years of experience in computational biology and human genetics. He serves as General Partner at Pioneer Fund and leads the Future of Health Fund. Prior to joining Pioneer Fund, Dr. Messina co-founded Cofactor Genomics, a company specializing in RNA and machine-learning-based diagnostics, where he led the development and clinical application of innovative diagnostic tools. Through his leadership at Pioneer Fund, he aims to advance the development of innovative health and biotechnology solutions, leveraging his extensive experience to support groundbreaking startups in the industry.

Relevant Content
Dave Messina
Dave Messina
General Partner, Pioneer Fund
Boyang Wang
Founder, Immortal Dragons
close-outline

Boyang Wang is an entrepreneur and investor with a strong background in computer science and a passion for the gaming and longevity industries. He is the founder of Immortal Dragons, a purpose-driven longevity fund dedicated to advancing research and innovation in life extension technologies. In addition to his entrepreneurial ventures, Boyang actively contributes to the longevity community. He serves as a senior venture fellow at Healthspan Capital, one of the most active longevity-focused venture capital funds. His engagement extends to speaking at conferences and participating in podcasts, where he shares insights on the convergence of technology, gaming, and life extension. Through his diverse endeavors, Boyang Wang continues to influence both the gaming industry and the field of longevity, driving forward initiatives that blend technological advancement with human health and well-being.

Relevant Content
Boyang Wang
Boyang Wang
Founder, Immortal Dragons
Edward Lando
Founder, Pareto Holdings
close-outline

​Edward Lando is an entrepreneur and investor with a focus on early-stage startups. He is the founder of Pareto Holdings, a venture studio and investment firm that has incubated over 10 companies and invested in more than 25 unicorns. In addition to his work at Pareto Holdings, Edward has co-founded several companies across various industries. He is also an active angel investor, with a portfolio that includes over 100 investments and 21 exits. ​Through his ventures and investments, Edward aims to empower innovative founders and contribute to the growth of transformative companies.​​

Relevant Content
Edward Lando
Edward Lando
Founder, Pareto Holdings
Chris Bradley
CEO, Matter Bio
close-outline

Chris Bradley is a serial entrepreneur and technologist with over 15 years of experience in biotech, health IT, and artificial intelligence. He is the founder and CEO of Matter Bio, a longevity-focused company dedicated to preserving genome integrity to combat aging and age-related diseases. Matter Bio employs a hub-and-spoke model to advance multiple scientific breakthroughs, including accurate mutation sequencing, reversal of somatic mutations, and clearance of pathological cells. Under his leadership, the company had a successful closing of seed round funding for the start of a clinical trial in solid state cancer.

Relevant Content
Chris Bradley
Chris Bradley
CEO, Matter Bio
Winnie Qiu
Co-founder, Avinasi Labs
close-outline

Winnie Qiu is the investment director of Paramita VC, co-founder of Avinasi Labs, the 1st AI-native data layer for longevity, which uses Web3 technology and decentralized users’ experiment to help scientists solve data accessibility bottlenecks in longevity research. She previously founded Haalthy, a company using data to assist over 100,000+ cancer patients to get access to new treatment 14 months in advance & saved over 300 million RMB in medical cost. She previously led a hardware (in healthcare) incubator at XbotPark, which incubated 80+ hardware startups and 8 unicorns in 8 years. Winnie received her master in engineering degree from MIT.

Relevant Content
Winnie Qiu
Winnie Qiu
Co-founder, Avinasi Labs
Priscila Chiavellini
Postdoctoral Scholar, Stanford University
close-outline

Priscila Chiavellini is a postdoctoral researcher in the Sebastiano Lab at Stanford University. She earned her Ph.D. from the Universidad Nacional de La Plata in Argentina, where she studied brain partial reprogramming in aged female rats as a strategy to reverse cognitive decline. Nearly two years ago, she joined Dr. Sebastiano's lab to investigate reproductive aging and explore partial reprogramming as a potential method to address it. Her current research is supported by a postdoctoral fellowship from the Stanford Maternal and Child Health Research Institute.

Relevant Content
Priscila Chiavellini
Priscila Chiavellini
Postdoctoral Scholar, Stanford University
Aimee Eyvazzadeh
Reproductive Endocrinologist and Fertility Specialist
close-outline

Dr. Aimee Eyvazzadeh is a reproductive endocrinologist and fertility specialist with over two decades of experience in clinical practice and public health education. Based in the San Francisco Bay Area, she is the founder of The Egg Whisperer brand and hosts a globally recognized fertility podcast and video series. Dr. Aimee is known for her innovative approaches to fertility care, including the TUSHY Method—a comprehensive diagnostic framework—and the Egg Freezing Party initiative, which aims to make fertility preservation more accessible and less stigmatized. She earned her M.D. from the David Geffen School of Medicine at UCLA, completed her residency in Obstetrics and Gynecology at Harvard Medical School, and pursued a fellowship in Reproductive Endocrinology and Infertility. Additionally, she holds a Master’s in Public Health Management and Policy from the University of Michigan.

Relevant Content
Aimee Eyvazzadeh
Aimee Eyvazzadeh
Reproductive Endocrinologist and Fertility Specialist

May 9-10

AI x Biology Week / May 9 - 16
Co-hosted with the Foresight Institute, this conference explores the powerful intersection of artificial intelligence and biology, with a special focus on its applications in longevity. From AI-driven drug discovery to computational biology, this event highlights the technologies revolutionizing healthspan extension.
Jason Kelly
Co-founder & CEO, Ginkgo Bioworks
close-outline

Jason Kelly is an entrepreneur and innovator with over a decade of experience in synthetic biology and biotechnology. He is the co-founder and CEO of Ginkgo Bioworks, a company pioneering the use of biological engineering to create sustainable solutions across industries. Jason's background is rooted in biological engineering and computational biology, with a focus on harnessing the power of living organisms to address global challenges. His work aims to revolutionize manufacturing, agriculture, and medicine by programming biology to create a more sustainable and healthier future.

Relevant Content
Jason Kelly
Jason Kelly
Co-founder & CEO, Ginkgo Bioworks
Joe Betts-Lacroix
Founder & CEO, Retro Biosciences
close-outline

Joe Betts-LaCroix is an American scientist and entrepreneur known for his discoveries in biophysics and for creating the world's smallest personal computer. He is currently the co-founder and CEO of Retro Biosciences, a company focused on developing therapeutics to increase healthy human lifespan by ten years. Joe has a background in earth sciences, biophysics, and computer hardware, and has contributed to significant advancements in both scientific research and technology innovation.

Relevant Content
Joe Betts-Lacroix
Joe Betts-Lacroix
Founder & CEO, Retro Biosciences
Derya Unutmaz
Professor, The Jackson Laboratory
close-outline

Derya Unutmaz, MD, is a distinguished professor at The Jackson Laboratory, renowned for his pioneering work on human T cell differentiation, activation, and regulation in immunity, diseases, and aging. With a medical degree from Marmara University, Istanbul, he also holds a concurrent professorship at the University of Connecticut Health Center. Dr. Unutmaz’s research has transformed understanding of T cell dysfunction in diseases like HIV and chronic fatigue syndrome. His work aims to optimize immune responses and develop therapies that combat age-related diseases, advancing healthier aging and immune system treatments.

Relevant Content
Derya Unutmaz
Derya Unutmaz
Professor, The Jackson Laboratory
Sonia Arrison
Angel Investor, 100 Plus Capital & Author, 100 Plus
close-outline

​Sonia Arrison is a best-selling author, analyst, entrepreneur, and investor with over two decades of experience studying the impact of new technologies on society. She is the founder of 100 Plus Capital, Lead Venture Partner at Portfolia, and serves as an advisor to Felicis Ventures, organizations that invest at the convergence of biology and technology. Sonia focuses her efforts on exponentially growing technologies and their societal implications. Her most recent book, 100 Plus: How the Coming Age of Longevity Will Change Everything, From Careers and Relationships to Family and Faith, addresses the social, economic, and cultural impacts of radical human longevity. Through her diverse endeavors, Sonia Arrison continues to influence the discourse on technology's role in shaping the future, particularly in the realms of human longevity and societal transformation.

Relevant Content
Sonia Arrison
Sonia Arrison
Angel Investor, 100 Plus Capital & Author, 100 Plus
Allison Duettmann
CEO & President, Foresight Institute
close-outline

Allison Duettmann is the President and CEO of the Foresight Institute, where she directs programs on Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs. She is also the Founder of Existential Hope and has co-edited works on superintelligence and co-authored books on future technologies. Allison holds an MS in Philosophy & Public Policy from the London School of Economics, focusing on AI Safety. She is a prominent advocate for leveraging technology to create a positive long-term future for humanity.

Relevant Content
Allison Duettmann
Allison Duettmann
CEO & President, Foresight Institute
Alex Voda
Co-founder & CEO, The Cat Health Company
close-outline

Alexandrul-Ioan Voda, DPhil, is a passionate leader in regenerative medicine, bioinformatics, and biotech. As CEO of The Cat Health Company, Alex leverages a diverse skill set combining wet-lab and computational sciences to drive advancements in biomedical research. A coding aficionado fluent in Python, R, and Bash, Alex specializes in machine learning, data structures, and algorithms. With a DPhil from the University of Oxford, he has contributed to groundbreaking work in inflammatory bowel disease genetics, aging clocks, and human health. His experience spans both academic and industry sectors, with a strong focus on innovation and scientific leadership.

Relevant Content
Alex Voda
Alex Voda
Co-founder & CEO, The Cat Health Company
Matthew Osman
Co-Founder, Stealth Biotech Startup
close-outline

Matthew Osman is an entrepreneur and AI specialist with a diverse background in finance and law. He holds a degree in Philosophy, Politics, and Economics from the University of Oxford. He co-founded Legit.ai, a life science AI startup that utilized natural language processing to streamline research and development processes. Under his leadership, Legit.ai was acquired by Clora in 2020. Matthew's work focuses on integrating AI technologies across various industries to drive innovation and efficiency.

Relevant Content
Matthew Osman
Matthew Osman
Co-Founder, Stealth Biotech Startup
Alexandru Băcița
Co-Founder & COO, The Cat Health Company
close-outline

Alexandru Băcița is a scientist and entrepreneur with extensive experience in drug discovery and development. He is the co-founder and Chief Operating Officer of The Cat Health Company (TCHC), a biotech startup dedicated to extending feline longevity through innovative therapies. Before co-founding TCHC, Alexandru served as a Senior Scientist at Charles River Laboratories, a leading provider of services for drug discovery and clinical trials. At TCHC, Alexandru focuses on developing computational pipelines to predict new therapies for rare diseases and age-related conditions in cats. His work aims to enhance feline health and longevity, providing pets with longer, healthier lives

Relevant Content
Alexandru Băcița
Alexandru Băcița
Co-Founder & COO, The Cat Health Company
Vincent Weisser
Founder & CEO, Prime Intellect
close-outline

Vincent Weisser is a dedicated advocate for decentralized science and AI, known for his work on projects like VitaDAO, which funds longevity research, and Molecule, a platform for scientific funding. He is passionate about democratizing access to cutting-edge technologies and scientific progress, aiming to create a future where advanced AI and biotechnology are accessible to all. Vincent's diverse interests and contributions span across AI, biotechnology, energy, and more, making him a key figure in the tech and science communities.

Relevant Content
Vincent Weisser
Vincent Weisser
Founder & CEO, Prime Intellect
Daniel Ives
Founder & CEO, Shift Bioscience
close-outline

Daniel Ives is the CEO and founder of Shift Bioscience, a company dedicated to reversing cellular aging using AI-guided cellular rejuvenation techniques. With a background in mitochondrial biology from the University of Cambridge, Daniel has been at the forefront of developing innovative solutions to combat age-related diseases. His work focuses on leveraging advanced machine learning and epigenetic aging clocks to discover new therapeutic interventions that can extend human healthspan.

Relevant Content
Daniel Ives
Daniel Ives
Founder & CEO, Shift Bioscience
Morgan Levine
Vice President of Computation, Altos Labs
close-outline

Dr. Morgan Levine is a prominent scientist specializing in the biology of aging, with extensive experience in academic research and computational biology. She currently serves as the Vice President of Computation at Altos Labs, a biotechnology company focused on restoring cell health and resilience through cell rejuvenation. Dr. Levine's scientific background encompasses bioinformatics, cellular biology, complex systems, and biostatistics. She is renowned for developing innovative methods to quantify the molecular and physiological changes that occur over an organism's lifetime, integrating interdisciplinary approaches to track the trajectories of aging cells and organisms. Her vision includes creating multi-scale computational models to elucidate how dynamic molecular states of cells lead to health and disease manifestations at various biological levels. Her work aims to uncover the principles of aging and develop interventions to promote healthy longevity.

Relevant Content
Morgan Levine
Morgan Levine
Vice President of Computation, Altos Labs
Sam Rodriques
Director & CEO, FutureHouse
close-outline

Dr. Sam Rodriques is a physicist, bioengineer, and entrepreneur with extensive experience in academic research and biotechnology innovation. He is the founder and CEO of FutureHouse, a research lab in San Francisco dedicated to developing an AI Scientist to accelerate scientific discovery. Before establishing FutureHouse in 2023, Dr. Rodriques led the Applied Biotechnology Laboratory at the Francis Crick Institute, where he focused on integrating bioengineering and business to advance medical and biological research. His notable inventions include technologies for spatial and temporal transcriptomics, brain mapping, gene therapy, and nanofabrication. Throughout his career, Dr. Rodriques has been committed to accelerating scientific research through innovative technologies and interdisciplinary approaches. His work aims to revolutionize the pace of discovery and provide global access to cutting-edge scientific, medical, and engineering expertise.

Relevant Content
Sam Rodriques
Sam Rodriques
Director & CEO, FutureHouse
Erika DeBenedictis
Co-founder, The Align Foundation
close-outline

Erika is a former astronomer and current synthetic biologist.  In 2021 she founded The Align Foundation, a nonprofit improving the reproducibility, scalability, and shareability of life science research. Align aims to make it easy to build upon the methods and data of other scientists, allowing scientific fields to accumulate data assets to train AI models.

Relevant Content
Erika DeBenedictis
Erika DeBenedictis
Co-founder, The Align Foundation
Fabio Boniolo
PostDoc, Broad Institute of MIT and Harvard
close-outline

​Fabio Boniolo is a computational scientist specializing in the application of statistical and machine learning techniques to understand complex diseases such as cancer. He is a Postdoctoral Research Fellow at the Dana-Farber Cancer Institute, Harvard Medical School, and the Broad Institute of MIT and Harvard, where he focuses on pediatric brain tumors and epigenetics. Fabio earned both his B.Sc. and M.Sc. in biomedical engineering from Politecnico di Milano. He completed his Ph.D. at the Technical University of Munich, developing new methods for patient stratification in precision oncology. Actively involved in the biotech startup scene, he collaborates with various venture funds and entrepreneurial associations. In 2021, Fabio served as an Italian delegate to the G7 Youth Summit.

Relevant Content
Fabio Boniolo
Fabio Boniolo
PostDoc, Broad Institute of MIT and Harvard
John Hallman
Technical Staff, OpenAI
close-outline

John Hallman is a machine learning engineer with a robust background in artificial intelligence research and applications. Currently, he serves as a Member of the Technical Staff at OpenAI, contributing to the development of advanced AI models. Prior to this role, John was a Machine Learning Engineer at AKASA, focusing on automating administrative tasks in healthcare to enhance efficiency and reduce costs. John's research experience includes an internship at Google Brain, where he concentrated on reinforcement learning projects. He holds a degree in mathematics from Princeton University and was awarded a silver medal in the International Mathematical Olympiad (IMO). His diverse expertise encompasses machine learning, artificial intelligence, and their practical applications across various industries.

Relevant Content
John Hallman
John Hallman
Technical Staff, OpenAI
Andrew White
Co-Founder, FutureHouse
close-outline

Andrew White is a researcher with over 50 peer-reviewed publications and books across the domains of large language models in chemistry, explainable artificial intelligence, statistical mechanics, and chemical engineering. He has won junior investigator awards from the National Science Foundation and National Institutes of Health along with professional and teaching awards for excellence as a chemical engineer. Andrew is an active member of the scientific community as a peer reviewer for over 30 journals, multiple national and private grant awarding institutions, and serves on the Chemical Sciences Roundtable at the National Academy of Science. Andrew is also a science communicator with large followings on X and LinkedIn and has been interviewed in multiple publications such as the New York Times, Bloomberg, Nature, Financial Times, and Science. Andrew serves on multiple scientific advisory boards across biotech. He has contributed to the ongoing debate around safety of artificial intelligence as a GPT-4 red teamer, speaking at multiple policy summits, and visiting the White House to advise multiple agencies.

Relevant Content
Andrew White
Andrew White
Co-Founder, FutureHouse
Stephen Malina
ML, Dyno Therapeutics
close-outline

Stephen Malina is a machine learning engineer and scientist working at the intersection of AI and gene therapy. He is the ML Engineering Lead at Dyno Therapeutics, where he develops and scales machine learning systems that accelerate the design of next-generation AAV gene therapy vectors. His work supports Dyno’s mission to reshape the gene therapy landscape through AI-powered precision. Stephen’s background spans both industry and academic research. He previously served as Dyno’s Head of Engineering and was the Principal Scientist leading the Machine-Guided Design Team. He also conducted research as a Graduate Research Assistant in the Knowles Lab, focusing on applying ML to molecular discovery. Before joining Dyno, Stephen built scalable backend infrastructure as a Senior Software Engineer at Uber and Compass, where he developed high-performance systems for real-time data pipelines and asynchronous image processing. His unique blend of engineering expertise and scientific curiosity now drives innovation in biotech, where he aims to make gene therapies safer, more efficient, and broadly accessible.

Relevant Content
Stephen Malina
Stephen Malina
ML, Dyno Therapeutics
Yisong Yue
Professor, Caltech
close-outline

Yisong Yue is a professor of Computing and Mathematical Sciences at the California Institute of Technology (Caltech), specializing in the theory and application of statistical machine learning. His research focuses on developing novel methods for interactive and structured machine learning, with applications spanning information retrieval, robotics, and experiment design. In addition to his academic role, Yisong serves as an advisor at Asari AI, where he contributes to designing AI agents capable of complex planning, abstraction, and verification tasks, facilitating collaboration between humans and AI systems.

Relevant Content
Yisong Yue
Yisong Yue
Professor, Caltech
Seth Paulson
Fellow and Developer, Methuselah Foundation
close-outline

​Seth Paulson is a seasoned software developer with extensive experience in bioinformatics and computational biology. At the Methuselah Foundation, he contributes to advancing regenerative medicine and extending healthy human lifespan. Seth leads the development of the Biolearn program for the Biomarkers of Aging Consortium, an open-source library dedicated to the implementation and application of aging biomarkers. His expertise in software development and bioinformatics plays a pivotal role in harmonizing existing biomarkers and unifying public datasets to facilitate cross-population validation studies.

Relevant Content
Seth Paulson
Seth Paulson
Fellow and Developer, Methuselah Foundation
Tom Roseberry
CTO and Co-founder, Olio Labs
close-outline

Tom Roseberry spent many years as an engineer in aerospace manufacturing before developing a strong interest in neuroscience through racing endurance sports. While working as a triathlon coach he retrained as a biologist followed by a PhD in neuro at UCSF. After a brief postdoc, he left academia to work at Neuralink on next-generation brain-machine interfaces. Through a series of startups he gravitated towards drug development, recently as the VP of Engineering, Comp Bio and Drug Development at Loyal. He recently co-founded Olio Labs, which leverages AI to design combination therapeutics with improved efficacy and fewer side effects.

Relevant Content
Tom Roseberry
Tom Roseberry
CTO and Co-founder, Olio Labs
Mark Woodward
Founder & CEO, Wake Bio
close-outline

Mark Woodward is a machine learning scientist and entrepreneur with expertise in computational biology and digital health. He is the Founder and CEO of Wake Bio, a company focused on accelerating biotech innovation through advanced AI technologies. Mark also serves as the Chief Science Officer at January AI, where he leads the development of predictive models that integrate wearable data and behavioral patterns to improve metabolic health. Mark holds a Ph.D. in Computer Science from Harvard University and both a Master's and Bachelor's degree in Computer Science from Stanford University. He has previously worked as a research resident at Google Brain and has contributed to publications in top machine learning conferences.

Relevant Content
Mark Woodward
Mark Woodward
Founder & CEO, Wake Bio
Sarah Constantin
Fellow, Renaissance Philanthropy
close-outline

Sarah Constantin is a Fellow at Renaissance Philanthropy, where she supports bold, high-impact initiatives. Prior to this, she served as Director of Corporate Development at Nanotronics, leading strategic partnerships and spearheading the deployment of the first real-time, AI-driven industrial process control system, Sarah is the founder of the Longevity Research Institute, a nonprofit dedicated to funding rigorous lifespan studies in aging biology. Her career spans multiple domains of applied machine learning and data science, with previous roles focused on autonomous vehicles at Starsky Robotics, drug discovery at Recursion Pharmaceuticals, and cybersecurity at Palantir Technologies. She holds a Ph.D. in mathematics from Yale University and an A.B. from Princeton University.

Relevant Content
Sarah Constantin
Sarah Constantin
Fellow, Renaissance Philanthropy
Halil Akin
Co-founder & Technical Staff, EvolutionaryScale
close-outline

Halil Akin is a scientist and entrepreneur specializing in artificial intelligence and computational biology. As Co-founder and Member of the Technical Staff at EvolutionaryScale, he focuses on developing large-scale foundation models for protein design and scientific intelligence. Halil co-authored a study demonstrating the use of language models to simulate 500 million years of evolution, generating novel functional proteins. His contributions have advanced AI-driven approaches to understanding and engineering biological systems.

Relevant Content
Halil Akin
Halil Akin
Co-founder & Technical Staff, EvolutionaryScale
Jaan Tallinn
Member of Board of Directors, Future of Life Institute
close-outline

Jaan Tallinn is a founding engineer of Skype and Kazaa. He is a co-founder of the Cambridge Centre for the Study of Existential Risk, the Future of Life Institute, and philanthropically supports other organizations tackling existential and catastrophic risk. Jaan serves on the AI Advisory Body at the United Nations, on the Board of the Center for AI Safety, and the Board of Sponsors of the Bulletin of the Atomic Scientists. He has previously served on the High-Level Expert Group on AI at the European Commission, as well as on the Estonian President’s Academic Advisory Board. He is also an active angel investor, a partner at Ambient Sound Investments, and a former investor director of the AI company DeepMind.

Relevant Content
Jaan Tallinn
Jaan Tallinn
Member of Board of Directors, Future of Life Institute
Alfredo Andere
Co–founder & CEO, Latch Bio
close-outline

Alfredo Andere is the co-founder and CEO of LatchBio, a platform that provides biology companies with the tools to store, transform, and analyze large data sets. Before founding LatchBio, he worked as a Data Engineer at Facebook and a Software Engineer at Google Brain, gaining valuable experience in handling large-scale data. Alfredo and his co-founders envisioned bringing high-quality computational infrastructure to the field of biology, and they dropped out of their senior year at UC Berkeley to pursue this goal. Since its inception, LatchBio has raised significant funding and serves numerous biotech companies.

Relevant Content
Alfredo Andere
Alfredo Andere
Co–founder & CEO, Latch Bio

May 17-18

Replacement Conference (*invite only) / May 16
Biostasis Week / May 17 -22
Organized in collaboration with the Global Cryonics Summit, this conference tackles the future of human preservation and organ replacement. From biostasis to regenerative medicine, explore the technologies that could redefine how we think about mortality.
Karl Pfleger
Founder, AgingBiotech.Info
close-outline

Karl Pfleger is a prominent angel investor and advocate for longevity research, known for his significant contributions to the biotech industry. He is an investor in Repair Biotechnologies, focusing on gene therapy for age-related diseases, and runs Aging Biotech Info, a valuable resource for the longevity community. Karl's background in machine learning and his dedication to supporting groundbreaking research make him a key figure in the fight against aging.

Relevant Content
Karl Pfleger
Karl Pfleger
Founder, AgingBiotech.Info
Max More
Founder, Extropy Institute
close-outline

Max More is a philosopher and futurist known for his work on transhumanism and the philosophy of extropy. He is the founder of the Extropy Institute and has served as President and CEO of the Alcor Life Extension Foundation. Max holds a degree in Philosophy, Politics, and Economics from Oxford University and a PhD in Philosophy from the University of Southern California. His writings and ideas have significantly influenced the transhumanist movement, focusing on the potential of emerging technologies to enhance human capabilities and extend life.

Relevant Content
Max More
Max More
Founder, Extropy Institute
Ralf Spindler
Head of Neural System Cryopreservation, 21st Century Medicine
close-outline

Ralf Spindler is a leading scientist and innovator with extensive expertise in neural systems cryopreservation. As the Head of Neural Systems Cryopreservation at 21st Century Medicine, he plays a pivotal role in advancing preservation techniques critical to the field of cryobiology. With a background in electrical and biomedical engineering, Ralf's research focuses on improving methods to preserve the human brain and other neural structures at ultra-low temperatures, with the goal of ensuring their integrity for future revival. His work is at the forefront of bridging the gap between cutting-edge science and long-term human preservation.

Relevant Content
Ralf Spindler
Ralf Spindler
Head of Neural System Cryopreservation, 21st Century Medicine
Emil Kendziorra
Founder & CEO, Tomorrow Bio
close-outline

Dr. Emil Kendziorra is the Founder and CEO of Tomorrow.Bio, a startup dedicated to advancing biostasis (cryonics) research and providing human cryopreservation services. He graduated summa cum laude from the University of Göttingen and has extensive experience in cancer research and entrepreneurship. Dr. Kendziorra has founded and led multiple tech and medical startups, including MedLanes and onFeedback. His vision is to build an organization that significantly contributes to the field of cryonics and promotes public awareness about its potential.

Relevant Content
Emil Kendziorra
Emil Kendziorra
Founder & CEO, Tomorrow Bio
Ariel Zeleznikow-Johnston
Author, "The Future Loves You" & Research Fellow, Monash University
close-outline

Ariel Zeleznikow-Johnston is a neuroscientist at Monash University, Australia, where he investigates methods for characterising the nature of conscious experiences. Ariel is also the author of "The Future Loves You: How and Why We Should Abolish Death", and has been featured in major publications like The Guardian and the BBC. His research interests range from the decline, preservation and rescue of cognitive function at different stages of the lifespan, through to comparing different people’s conscious experience of colour. By contributing to research that clarifies the neurobiological, cognitive, and philosophical basis of what it is to be a person, he hopes to accelerate the development of medical infrastructure that will help prevent him and everyone else from dying.

Relevant Content
Ariel Zeleznikow-Johnston
Ariel Zeleznikow-Johnston
Author, "The Future Loves You" & Research Fellow, Monash University
Andrew McKenzie
Research Scientist at Oregon Brain Preservation
close-outline

Throughout his career, Andrew McKenzie has contributed to the understanding of brain cell type-specific gene expression and co-expression network architectures. His work aims to advance the field of neuroscience through innovative research and collaboration. Dr. McKenzie's research focuses on brain banking, ischemic alterations in the brain, and long-term preservation methods. His scholarly work emphasizes structural brain preservation, guiding the research directions at Oregon Brain Preservation, a non-profit organization.

Relevant Content
Andrew McKenzie
Andrew McKenzie
Research Scientist at Oregon Brain Preservation
Kai Micah Mills
Founder, Cryopets & CryoDAO
close-outline

Kai Micah Mills is the CEO of Cryopets, a startup specializing in cryopreservation for pets, and a co-founder of CryoDAO, a decentralized organization funding cryonics research. With a background as a tech entrepreneur and Thiel Fellow, Kai is dedicated to advancing cryopreservation technologies and making significant contributions to the field of life extension.

Relevant Content
Kai Micah Mills
Kai Micah Mills
Founder, Cryopets & CryoDAO
Alice Gilman
COO & Chief of Staff, R3 Biotechnology
close-outline

Alice Gilman is a global leader in longevity innovation and strategic operations, with experience organizing over 80 events across 40+ countries. She is using her expertise to solve the global organ shortage crisis and develop deep tech anti-aging technologies. As a consultant and researcher in longevity labs and startups, she brings deep expertise in investor relations, brand strategy, and operational leadership. Alice co-founded Homespace, securing $500K in funding, and has driven impactful initiatives in AI, biotech, and healthspan-focused ventures. With roles spanning COO, business consulting, and founder residencies, Alice combines entrepreneurial vision and operational excellence to pioneer solutions for living longer, healthier lives. Alice is an advocate for deregulating stem cell research.

Relevant Content
Alice Gilman
Alice Gilman
COO & Chief of Staff, R3 Biotechnology
James Arrowood
CEO, Alcor Life Extension Foundation
close-outline

James Arrowood is an entrepreneur, legal expert, and executive with extensive experience in the life extension and biotechnology sectors. He is the CEO of the Alcor Life Extension Foundation, where he has been instrumental in guiding the organization since 2015. James initially joined Alcor as outside General Counsel, helping navigate complex legal and business challenges. He has also served on the board of directors for a major local non-profit and as its public relations chair, contributing to his long-standing expertise in media and public relations. His work focuses on advancing Alcor’s mission and engaging with the wider conversation on cutting-edge technologies aimed at extending human lifespan.

Relevant Content
James Arrowood
James Arrowood
CEO, Alcor Life Extension Foundation
Ralph Merkle
Nanotechnologist & Board Member, Alcor Life Extension Foundation
close-outline

Ralph C. Merkle is a computer scientist and cryptographer with over 40 years of experience in academic research and technological innovation. He is a board member at the Alcor Life Extension Foundation, an organization focused on cryonics and life extension. Ralph's scientific background encompasses public key cryptography, cryptographic hashing, and nanotechnology. His work aims to advance secure communication systems and explore technologies to extend human life.

Relevant Content
Ralph Merkle
Ralph Merkle
Nanotechnologist & Board Member, Alcor Life Extension Foundation
Aschwin de Wolf
Owner and CEO, Advanced Neural Biosciences & Author, "Preserving Minds, Saving Lives"
close-outline

Aschwin de Wolf is a Dutch-born American cryobiologist and entrepreneur with extensive experience in cryonics research and writing. He is the co-founder and Chief Executive Officer of Advanced Neural Biosciences (ANB), a biomedical research company established in 2008. ANB focuses on developing low-temperature technologies to preserve central nervous tissue and whole brains, aiming to advance brain banking, pharmacological drug discovery, and the study of neurodegenerative diseases. He co-authored the first comprehensive human cryopreservation procedures manual and authored the first medical biostasis protocol. Aschwin's involvement in cryonics extends to founding the Depressed Metabolism blog in 2007, which later evolved into Biostasis.com. He also co-founded and served as president of the Institute for Evidence-Based Cryonics. Through his work, Aschwin aims to advance the science and application of cryopreservation techniques, contributing to the potential for future medical applications and the extension of human life.

Relevant Content
Aschwin de Wolf
Aschwin de Wolf
Owner and CEO, Advanced Neural Biosciences & Author, "Preserving Minds, Saving Lives"
Borys Wrobel
Scientific Director, European Institute for Brain Research
close-outline

Borys Wróbel is a biologist and computer scientist with extensive experience in academic research and leadership. He serves as the Scientific Director of the European Institute for Brain Research (EIBR), where he is pioneering the development of a brain bank utilizing innovative methods to preserve neural tissue at the nanoscale level. Dr. Wróbel's interdisciplinary research spans brain banking, computational neuroscience, computational biology, and molecular biology. In his role at EIBR, Dr. Wróbel is dedicated to advancing the preservation of neural structures, aiming to enhance our understanding of the brain and its complexities.

Relevant Content
Borys Wrobel
Borys Wrobel
Scientific Director, European Institute for Brain Research
Brian Wowk
CTO, 21st Century Medicine
close-outline

Brian G. Wowk is a medical physicist and cryobiologist with over 20 years of experience in cryobiological research and technology development. He serves as the Chief Technology Officer at 21st Century Medicine, where he has been instrumental in advancing cryopreservation techniques. In his role at 21st Century Medicine, Dr. Wowk continues to lead efforts in developing advanced cryobiological technologies, aiming to improve the preservation and longevity of biological tissues and organs. Dr. Wowk's notable contributions include the discovery and development of synthetic molecules that mimic natural antifreeze proteins, commonly referred to as "ice blockers." These innovations have been pivotal in enabling the vitrification and successful transplantation of complex mammalian organs, such as kidneys. He is presently refining electromagnetic warming methods for vitrified whole organs.

Relevant Content
Brian Wowk
Brian Wowk
CTO, 21st Century Medicine
Rebecca Ziegler
Director, Cryosphere Foundation
close-outline

Rebecca Ziegler is a cryonics specialist with a focus on advancing human cryopreservation technologies. She helped organize the 2024 Global Cryonics Summit, which brought together cryonics experts to develop a cohesive cryonics community and spark new ideas. She served as a Product Manager at Tomorrow Bio, a company dedicated to making cryonics more accessible and reliable through state-of-the-art preservation techniques and emergency standby services. Now she serves as a Director at the Cryosphere Foundation, with the goal to bring together experts and foster a cohesive cryonics community. Her work aims to refine cryonics processes and make human cryopreservation more accessible and effective.

Relevant Content
Rebecca Ziegler
Rebecca Ziegler
Director, Cryosphere Foundation
Eric Magro
Director of Operations, LongeviPAC
close-outline

Eric Magro is an entrepreneur and advocate for life extension, dedicated to advancing the fields of cryonics and longevity policy. He is the Co-Founder of Cryosphere, a platform focused on fostering community and innovation in cryonics. As Director of Operations at LongeviPAC, Eric works to shape policies that support life extension technologies and research. He helped organize the 2024 Global Cryonics Summit, which brought together experts to provide the space and resources to push projects forward. His efforts bring together scientific progress and public policy, ensuring that advancements in longevity science receive the attention and support they deserve. Through his work, Eric aims to accelerate the development of life-preserving technologies and expand access to cutting-edge longevity solutions.

Relevant Content
Eric Magro
Eric Magro
Director of Operations, LongeviPAC
Max Marty
Director, Cryosphere Foundation
close-outline

Max Marty is a serial entrepreneur and active member of the cryonics community. In 2011, Max co-founded Blueseed, a project aimed at creating a floating startup incubator off the coast of California. The initiative sought to provide a visa-free environment for international entrepreneurs to collaborate and innovate near Silicon Valley. He is the creator of The Cryosphere, an online cryonics-focused community, fostering discussions among enthusiasts and professionals. He helped organize the 2024 Global Cryonics Summit, which connected experts from the industry and community. Max also co-hosts The Cryosphere Podcast, where he engages with key figures in the field to explore the scientific, social, and philosophical aspects of cryonics. Through his initiatives, Max aims to advance public understanding and acceptance of cryonics as a viable option for life extension. Max's diverse entrepreneurial ventures reflect his commitment to pioneering unconventional solutions and fostering global collaboration in technology and life extension.

Relevant Content
Max Marty
Max Marty
Director, Cryosphere Foundation
Daniel Walters
Director, Cryosphere Foundation
close-outline

Daniel Walters is a prominent advocate for cryonics and life extension, with extensive experience in community engagement and digital outreach. He is the co-host of the Cryosphere Podcast, where he explores the latest advancements, challenges, and philosophies surrounding cryopreservation. He helped organize the 2024 Global Cryonics Summit, which brought together experts to foster a cohesive cryonics community. With deep roots in the cryonics community, Daniel has played a key role in fostering discussion and awareness. As Community Outreach Coordinator at Alcor Life Extension Foundation, Daniel is focused on transforming Alcor’s digital presence by enhancing member communications, expanding social media engagement, and modernizing its online platforms. His work bridges the gap between scientific progress and public awareness, ensuring that cryonics continues to gain traction as a viable approach to life extension.

Relevant Content
Daniel Walters
Daniel Walters
Director, Cryosphere Foundation

May 24-25.

Policy, Media and Ethics Week / May 23 - 29
OrganizedBringing together regulatory leaders, advocates, and media influencers, this conference addresses the policy landscape and public discourse surrounding longevity. Featuring experts from the FDA, NIH, NIA, and beyond, this summit is where science meets policy and communication strategy.
Robin Hanson
Assoc. Professor, Economics, George Mason University
close-outline

Robin Hanson is an associate professor of economics at George Mason University and a research associate at the Future of Humanity Institute at Oxford University. He is known for his pioneering work on prediction markets, also known as idea futures, and has been a key figure in developing these markets for various applications. Robin has authored several influential books, including "The Age of Em: Work, Love and Life When Robots Rule the Earth" and "The Elephant in the Brain: Hidden Motives in Everyday Life." His research spans a wide range of topics, from spatial product competition to the bioethics of healthcare, and he is a prominent advocate for futarchy, a form of governance based on prediction markets.

Relevant Content
Robin Hanson
Robin Hanson
Assoc. Professor, Economics, George Mason University
Jason Sorens
Founder, The Free State Project
close-outline

Jason Sorens is an American political scientist and conservative libertarian activist, best known for founding the Free State Project in 2001. He holds a PhD in political science from Yale University and a BA in economics and philosophy from Washington and Lee University. Jason has taught at several prestigious institutions, including Yale, Dartmouth, and the University at Buffalo. His research focuses on fiscal federalism, public policy in federal systems, secessionism, and ethnic politics. He is also a Senior Research Fellow at the American Institute for Economic Research (AIER) and president of the Ethics and Economics Education of New England (E3NE).

Relevant Content
Jason Sorens
Jason Sorens
Founder, The Free State Project
Breanna Deutsch
Author, "Finding the Fountain"
close-outline

Breanna Deutsch is a policy expert and author, known for her work in political communications and advocacy for life extension technologies. She is the Secretary of the Board at A4LI and the author of "Finding the Fountain: Why Government Must Unlock Biotech's Potential to Maximize Longevity." Breanna's efforts focus on encouraging policymakers to support aging research and promote healthier lifespans through government initiatives.

Relevant Content
Breanna Deutsch
Breanna Deutsch
Author, "Finding the Fountain"
Arkadi Mazin
Science Journalist, Lifespan.io
close-outline

Arkadi Mazin is a seasoned journalist and op-ed author with a passion for learning and exploration. His interests span from politics to science and philosophy. Having studied economics and international relations, he is particularly interested in the social aspects of longevity and life extension. Arkadi is dedicated to promoting the idea that life extension is an achievable and noble goal that deserves greater attention and action from society.

Relevant Content
Arkadi Mazin
Arkadi Mazin
Science Journalist, Lifespan.io
Alberto Aparicio
Assistant Professor, The University of Texas Medical Branch
close-outline

Alberto Aparicio is an Assistant Professor in the Department of Bioethics and Health Humanities. He completed postdoctoral fellowships at the Global Observatory for Genome Editing at Harvard University and the Alexander von Humboldt Biological Resources Research Institute in Colombia. Dr. Aparicio holds a PhD in Science and Technology Studies from University College London and an MPhil in Technology Policy from Cambridge University. With experience in policy, academia, consultancy, and government, his research focuses on the governance of emerging biotechnology and the societal implications of bioscience, including evolving attitudes toward life and technoscience.

Relevant Content
Alberto Aparicio
Alberto Aparicio
Assistant Professor, The University of Texas Medical Branch
Kamen Shoylev
Owner & Managing Partner, New Balkans Law Office
close-outline

Kamen Shoylev is a dual-qualified lawyer, practicing at both the Bulgarian and English Bars. As co-managing partner at New Balkans Law Office, he provides expert advice on corporate, commercial, regulatory, and IP law, focusing on cross-border issues between Bulgaria, the EU, and the UK. Kamen’s legal expertise spans corporate disputes, EU law, and intellectual property. With a keen interest in innovation and longevity, he integrates his knowledge of science, technology, and investment ethics into his work. Kamen holds a B.A. in Law from Cambridge University and is committed to advancing entrepreneurial and legal solutions globally.

Relevant Content
Kamen Shoylev
Kamen Shoylev
Owner & Managing Partner, New Balkans Law Office
Hisham Badaruddin
CEO, Bartley Clinic
close-outline

Dr. Hisham Badaruddin is a medical doctor and public health specialist with over 25 years of experience in the healthcare system. He is the founder and CEO of Bartley Clinic, a general practice in Singapore that integrates primary care with longevity medicine to make advanced healthcare more accessible. At Bartley Clinic, Dr. Hisham focuses on preventive medicine, health screening, lifestyle medicine, and modern longevity science, aiming to optimize health and extend disease-free years for his patients. Throughout his career, Dr. Hisham has held leadership roles in biopharma, healthcare insurance, and telehealth companies.

Relevant Content
Hisham Badaruddin
Hisham Badaruddin
CEO, Bartley Clinic
Dylan Livingston
Founder & CEO, A4LI
close-outline

Dylan Livingston is the Founder and President of the Alliance for Longevity Initiatives (A4LI), a non-profit organization focused on advocating for policies that promote healthy human lifespan. He has a background in grassroots political organizing and has worked with various political campaigns, including the Biden campaign in Pennsylvania. Dylan is passionate about increasing equitable access to next-generation therapies and has been involved in the longevity community since childhood, influenced by his father's early-stage investments in futuristic technologies.

Relevant Content
Dylan Livingston
Dylan Livingston
Founder & CEO, A4LI
John Davis
Author, "New Methuselahs: The Ethics of Human Life Extension"
close-outline

John Davis is a philosopher and author, best known for his work "New Methuselahs: The Ethics of Life Extension." In this book, Davis explores the ethical implications of extending human life, addressing issues such as desirability, unequal access, and potential overpopulation. His philosophical discussions provide a comprehensive guide to the ethical considerations of life extension, making a compelling case for funding research in this field.

Relevant Content
John Davis
John Davis
Author, "New Methuselahs: The Ethics of Human Life Extension"
Patrick Linden
Author, "The Case Against Death"
close-outline

Patrick Linden is a philosopher and author, known for his work on the ethics of life extension and the philosophy of death. He has taught at various prestigious institutions, including Lund University, UCL, and NYU. His book, "The Case Against Death," argues that death is an evil that should be combated through anti-aging science and radical life extension. Linden's work challenges traditional views on mortality and advocates for a future where humans can live significantly longer, healthier lives.

Relevant Content
Patrick Linden
Patrick Linden
Author, "The Case Against Death"
Gennady Stolyarov II
Chairman, U.S. Transhumanist Party
close-outline

Gennady Stolyarov II is a Belarusian-American libertarian and transhumanist writer, actuary, and civil servant. He is best known for his book "Death is Wrong," which argues that death is an enemy to be overcome through technology. Gennady is also the Chairman of the Transhumanist Party, advocating for life extension and the use of science and technology to enhance human capabilities.

Relevant Content
Gennady Stolyarov II
Gennady Stolyarov II
Chairman, U.S. Transhumanist Party
Felix Werth
Chairman, The German Party for Rejuvenation
close-outline

Felix Werth is a biochemist and political advocate, best known for founding the Party for Rejuvenation Research in Germany. The party focuses on accelerating the development of regenerative medicine to extend healthy human lifespans. As the party's leader, Felix is dedicated to raising public awareness and support for rejuvenation research, aiming to prevent age-related diseases and promote longer, healthier lives.

Relevant Content
Felix Werth
Felix Werth
Chairman, The German Party for Rejuvenation
John Martin Fischer
Professor of Philosophy, University of California, Riverside
close-outline

John Martin Fischer is a Distinguished Professor of Philosophy at the University of California, Riverside, and a leading contributor to the philosophy of free will and moral responsibility. He is known for his theory of semi-compatibilism, which explores the relationship between free will and moral responsibility. Fischer has also made significant contributions to the metaphysics of death and the philosophy of religion. He has served as President of the American Philosophical Association, Pacific Division, and was elected a Fellow of the American Academy of Arts and Sciences in 2024.

Relevant Content
John Martin Fischer
John Martin Fischer
Professor of Philosophy, University of California, Riverside
Melissa King
COO & Co-Founder, Healthspan Action Coalition
close-outline

Melissa King is a strategic management and communications executive with extensive experience in global healthcare and research policy. She is the Chief Operating Officer and a Founding Board Member of the Healthspan Action Coalition, an organization dedicated to promoting healthy aging and advancing medical research to reduce the burden of chronic diseases. Throughout her career, Melissa has been a passionate advocate for patients suffering from chronic illnesses, focusing on accelerating medical advancements and ensuring equitable access to innovative treatments. She has played a pivotal role in engaging multiple stakeholders and effectively communicating complex scientific concepts to diverse audiences.

Relevant Content
Melissa King
Melissa King
COO & Co-Founder, Healthspan Action Coalition
Niklas Anzinger
Co-Founder & CEO, Infinita City
close-outline

Niklas Anzinger is an entrepreneur and investor with a focus on innovative urban development and regulatory frameworks. He is the founder and CEO of Infinita City, an organization dedicated to leveraging special regulatory zones to accelerate biomedical progress. Niklas is also the founder and general partner of Infinita VC, a venture capital firm based in the charter city of Próspera in Honduras, focusing on charter cities and alternative jurisdictions. His work creates scalable regulatory solutions that can be applied across multiple jurisdictions, fostering environments conducive to innovation and progress.

Relevant Content
Niklas Anzinger
Niklas Anzinger
Co-Founder & CEO, Infinita City
Andrés Gómez Emilsson
Director of Research, Qualia Research Institute
close-outline

Andrés Gómez Emilsson is a consciousness researcher and transdisciplinary scientist exploring the nature of subjective experience. He is the Director of Research at the Qualia Research Institute, an organization dedicated to developing a precise scientific understanding of qualia and its implications for well-being. His work integrates insights from neuroscience, computational modeling, and philosophy to advance the study of consciousness. Andrés is particularly interested in the structure of phenomenology, the neurotechnology of altered states, and the ethical implications of enhancing subjective experience. Through his research, he aims to uncover fundamental principles of consciousness and develop frameworks for its rigorous quantification and optimization.

Relevant Content
Andrés Gómez Emilsson
Andrés Gómez Emilsson
Director of Research, Qualia Research Institute
Eric Magro
Director of Operations, LongeviPAC
close-outline

Eric Magro is an entrepreneur and advocate for life extension, dedicated to advancing the fields of cryonics and longevity policy. He is the Co-Founder of Cryosphere, a platform focused on fostering community and innovation in cryonics. As Director of Operations at LongeviPAC, Eric works to shape policies that support life extension technologies and research. He helped organize the 2024 Global Cryonics Summit, which brought together experts to provide the space and resources to push projects forward. His efforts bring together scientific progress and public policy, ensuring that advancements in longevity science receive the attention and support they deserve. Through his work, Eric aims to accelerate the development of life-preserving technologies and expand access to cutting-edge longevity solutions.

Relevant Content
Eric Magro
Eric Magro
Director of Operations, LongeviPAC
Nico Arcino
CTO, Primasun
close-outline

​Nico Arcino is a seasoned technology leader with extensive experience in both dynamic startups and large foundational institutions. He currently serves as the Chief Technology Officer at Primasun, a company dedicated to advancing sleep health through innovative technological solutions. Prior to joining Primasun, Nico held the position of Senior Director of Strategic Partnerships at Kaiser Permanente, where he played a pivotal role in forging collaborations that enhanced healthcare delivery and technological integration. Throughout his career, Nico has been recognized as a health and tech innovator, consistently contributing to advancements at the intersection of healthcare and technology. His diverse background and strategic insights continue to drive Primasun's mission to revolutionize sleep health.

Relevant Content
Nico Arcino
Nico Arcino
CTO, Primasun
Mikhail Batin
Co-founder, Open Longevity
close-outline

Mikhail Batin is a Russian entrepreneur and activist dedicated to combating aging and extending human lifespan. He is the co-founder and CEO of Open Longevity, a nonprofit organization that promotes open research and grassroots activism in the field of longevity science. Through initiatives like Open Genes—a database of longevity-related genes—and Aging Nets, which applies network science to aging, Batin aims to democratize aging research and involve the public in scientific endeavors. In 2008, Batin founded the Science for Life Extension Foundation, further demonstrating his commitment to advancing longevity research. His advocacy extends to organizing events such as the "Say Forever Day," a monthly campaign where volunteers engage the public in conversations about life extension, raising awareness and fostering community involvement. Batin's career also includes political engagement; he served as a deputy in the Kostroma Oblast Duma and chaired the Federation of Trade Unions of the Kostroma region. His multifaceted approach combines scientific initiatives, public activism, and policy involvement to address the challenges of aging and promote the development of life-extension technologies.

Relevant Content
Mikhail Batin
Mikhail Batin
Co-founder, Open Longevity
Meliza Mokrani
Founder, Worthy Self-Care Studio
close-outline

Meliza Mokrani is a wellness entrepreneur and certified health coach with over a decade of experience helping individuals cultivate stress resilience and long-term well-being. Her work focuses on nervous system regulation through a blend of science-backed, somatic practices designed to down-regulate stress and support mind-body healing. She is the founder of WORTHY Self-Care Studio, a transformative wellness space in Berkeley, California, and WORTHY Breath & Body, a nervous system-friendly movement and breathwork studio offering trauma-informed workouts for recovery and regulation. Meliza draws on her expertise as a master breathwork facilitator, health coach, and Trauma Specialist—as well as her lived experience as a trauma survivor—to guide people toward real, lasting change. She is also the creator of Regulate & Rise, an eight-week neuroscience-based coaching program that helps participants rewire stress patterns and build emotional resilience. Her work is rooted in a heart-led, human-first approach that makes healing accessible through her studios and the nonprofit WORTHY Wellness Initiative.

Relevant Content
Meliza Mokrani
Meliza Mokrani
Founder, Worthy Self-Care Studio

++

Join us at Vitalist Bay Apr 4 - May 29

Become a Resident

room + co-working + conf/events

$1850/month and up

check-circle
Enjoy onsite co-living (weekly / monthly)
check-circle
Access onsite co-working space
check-circle
Access all conferences and events during your stay
Apply
(Scholarships available)

Get an Event Pass

conferences + events

$219/week and up

check-circle
Conference ticket
check-circle
Access to all events (weekly / monthly)
Join now
(Scholarships available)

Apr 5-7

Unlimited Health Week / Apr 4 - 10
A deep dive into cutting-edge therapeutics and interventions that can be used today, along with innovations expected within the next 6 to 24 months. From precision medicine to emerging treatments, this conference is the go-to event for those eager to optimize their health with the latest advancements.

Apr 12-13

In collaboration with the Biomarkers of Aging Consortium, this event showcases the latest breakthroughs in longevity research, spanning from lab discoveries to translational science. Designed for those pushing the boundaries of aging interventions, this conference highlights cutting-edge innovations that may not yet be in the clinic but are shaping the future of human lifespan extension.

Apr 19-20

DeSci & Network State Week / April 18 - 24
Exploring the frontier of decentralized science, this conference focuses on new funding models, blockchain applications, and novel research ecosystems designed to accelerate biomedical breakthroughs. Whether you’re building in DeSci or just curious about its potential, this event will illuminate the path forward.

Apr 25-27

Vitalist Bay Week / Apr 25 - May 1
The flagship event of Vitalist Bay—where the biggest names in longevity, biotech, AI, and policy converge. This is the essential summit for those shaping the longevity movement, featuring high-impact discussions, groundbreaking announcements, and a gathering of top researchers, investors, and advocates.

Guarantee your place at Vitalist Bay. Limited spots.

Apr 4 – May 29. 2025.

SIGN UP
Sign up

Experience

Conferences & Events

crowd-stuart-park-square

CONNECT with others

Weekly thematic focus -- from Longevity Clinics and Doctors, to Biostasis and Biomarkers.

Top experts converge on our campus for conferences, workshops, and meetups.

Residents and co-working space members can self-organize community events.

Health Optimization

running

ELEVATE your health.
EAT healthy.
GET fit.

We're making it easy to be healthy.

Get your data with onsite biomarker diagnostics (Dexa Scan, VO2 max, biobanking).

Effortlessly eat healthy with our meal plan providers.

Stay committed with exercises and activities led by best-in-class instructors.

Free your body with dance and movement.

Co-working

Front-2D

WORK on aging together

Supercharge your productivity and collaboration in an energetic environment, with ambitious Vitalists fighting aging & death on all fronts. 

Included in Vitalist Bay Passport.
Open to non-residents.  

  • 100 person capacity (open to non-residents)
  • Offices with desks + monitors
  • Video call booths
  • Fast wifi
  • Bay Area Vitalist community space
  • Access community events and conferences
  • Communal kitchens
  • Gym access
  • Sauna access
  • Parking (limited availabilty)
  • Whiteboard walls, everywhere

Co-living Residences

vitalist bay hero

LIVE together

Vitalist Bay will take place at Lighthaven, a vibrant private campus in Berkeley, California -- just across the bridge from San Francisco.

The campus includes:

  • 50 bedrooms (variety of options) 
  • Co-working community space
  • Multiple indoor & outdoor common spaces
  • Working spaces/offices
  • Communal kitchens
  • Gym
  • Sauna
  • On site laundry
  • Parking (limited availabilty)
  • Whiteboard walls, everywhere
Vitalist
asterisk-2 1asterisk-2 1
Vitalist
asterisk-2 1
Bay
Bay
asterisk-2 1
Vitalist
asterisk-2 1
Bay
asterisk-2 1
Vitalist